I think there’s confusion if the first 6 from phase 1, dose escalation count in the first 9 for phase 2. If not then we can’t conclude anything yet,as KB said, It will only be stopped for futility if no response in first 9. Since they've said 3 in phase 2 I’m assuming first 6 don’t count. So we may only know of 3 being treated at time of update.
Now if at least one of the first 9 show a response it continues and recruits an extra 8. Now, I think given previous trial and phase 1 results, it’s quite probably there has already been at least 1 response and my guess is the Sheba article may be in part a promotion for awareness to get the extra 8.
if 3 patients respond this might bring an early end to trial.
General Comments / Chat, page-8085
-
- There are more pages in this discussion • 3,041 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAC (ASX) to my watchlist
|
|||||
Last
$1.94 |
Change
0.000(0.00%) |
Mkt cap ! $331.3M |
Open | High | Low | Value | Volume |
$1.93 | $1.97 | $1.90 | $199.8K | 103.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 2584 | $1.94 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.96 | 1306 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 2584 | 1.940 |
2 | 1313 | 1.935 |
2 | 5996 | 1.930 |
2 | 5581 | 1.925 |
2 | 2139 | 1.920 |
Price($) | Vol. | No. |
---|---|---|
1.955 | 1306 | 2 |
1.960 | 1328 | 2 |
1.965 | 4395 | 2 |
1.970 | 229 | 1 |
1.975 | 2000 | 1 |
Last trade - 11.45am 16/07/2024 (20 minute delay) ? |
Featured News
RAC (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, CEO / Non-Exec Director
James Graham / Dr Alan Dunton
CEO / Non-Exec Director
SPONSORED BY The Market Online